Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dianexin - Kowa

Drug Profile

Dianexin - Kowa

Alternative Names: Annexin A5 - Kowa; Annexin V - Kowa; Calphobindin; Caphobindin 1; Carfovindin; CPB I; KK 001; rCPB I

Latest Information Update: 17 Sep 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Akita University; Kowa
  • Class Anti-inflammatories; Anti-ischaemics; Anticoagulants; Antithrombotics; Biological peptides; Calcium binding proteins; Eye disorder therapies; Recombinant fusion proteins
  • Mechanism of Action Phosphatidylserine receptor modulators; Phospholipase A2 inhibitors; Urokinase-type plasminogen activator stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Blood coagulation disorders

Most Recent Events

  • 18 Feb 2005 Discontinued - Preclinical for Coagulation disorders in Japan (unspecified route)
  • 14 Jan 2004 No development reported - Preclinical for Coagulation disorders in Japan (unspecified route)
  • 19 Mar 2002 Calphobindin 1 is now called annexin V
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top